Literature DB >> 34453663

Shank3 Deficiency is Associated With Altered Profile of Neurotransmission Markers in Pups and Adult Mice.

Stanislava Bukatova1, Emese Renczes2, Alexandra Reichova1, Johan Filo2, Anna Sadlonova1, Boris Mravec1,3, Daniela Ostatnikova3, Jan Bakos4,5, Zuzana Bacova1.   

Abstract

Alterations in the balance between excitation and inhibition, especially in the brain's critical developmental periods, are considered an integral part of the pathophysiology of autism. However, the precise mechanisms have not yet been established. SH3 and multiple Ankyrin repeat domains 3 (Shank3) deficient mice represent a well-established transgenic model of a neurodevelopmental disorder with autistic symptomatology. In this study, we characterize the consequences of Shank3 deficiency according to (1) expression of specific markers of different neuronal populations in pups and adult mice and (2) social behaviour and anxiety in adult mice. Our research found enhanced expression of serotonin transporter and choline acetyltransferase in the hippocampus and hypothalamus in Shank3-deficient pups. We demonstrated marked brain region differences in expression of excitatory glutamatergic markers in pups and adult Shank3 deficient mice. We also observed reduced expression of inhibitory GABAergic markers and GABA receptor subunits in several brain areas in both pups and adult Shank3 deficient mice. Further analysis of dopaminergic brain areas (nucleus accumbens, ventral tegmental area) revealed lower expression levels of GABAergic markers in adult Shank3 deficient mice. Adult Shank3- deficient mice exhibited excessive repetitive behaviour, a higher level of anxiety, and lower locomotor activity. Our data support the theory of an imbalance between excitatory and inhibitory neurotransmission in conditions of abnormal SHANK3 protein. We therefore suggest that autism-like conditions are accompanied by reduced expression of GABAergic markers in the brain during early development as well as in the adult age, which could be associated with long-lasting behavioural abnormalities.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anxiety; Autism; GABA; Locomotor activity; Serotonin transporter; Shank3

Mesh:

Substances:

Year:  2021        PMID: 34453663     DOI: 10.1007/s11064-021-03435-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

1.  Synaptic and vesicular coexistence of VGLUT and VGAT in selected excitatory and inhibitory synapses.

Authors:  Johannes-Friedrich Zander; Agnieszka Münster-Wandowski; Irene Brunk; Ingrid Pahner; Gisela Gómez-Lira; Uwe Heinemann; Rafael Gutiérrez; Gregor Laube; Gudrun Ahnert-Hilger
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

Review 2.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

3.  Environmental enrichment modulates affiliative and aggressive social behaviour in the neuroligin-3 R451C mouse model of autism spectrum disorder.

Authors:  E L Burrows; L Koyama; C May; E L Hill-Yardin; A J Hannan
Journal:  Pharmacol Biochem Behav       Date:  2020-05-29       Impact factor: 3.533

Review 4.  Resolving the Synaptic versus Developmental Dichotomy of Autism Risk Genes.

Authors:  Whitney E Heavner; Stephen E P Smith
Journal:  Trends Neurosci       Date:  2020-02-22       Impact factor: 13.837

5.  Validation of existing diagnosis of autism in mainland China using standardised diagnostic instruments.

Authors:  Xiang Sun; Carrie Allison; Bonnie Auyeung; Zhixiang Zhang; Fiona E Matthews; Simon Baron-Cohen; Carol Brayne
Journal:  Autism       Date:  2015-03-10

6.  Dorsal Medial Habenula Regulation of Mood-Related Behaviors and Primary Reinforcement by Tachykinin-Expressing Habenula Neurons.

Authors:  Yun-Wei A Hsu; Glenn Morton; Elizabeth G Guy; Si D Wang; Eric E Turner
Journal:  eNeuro       Date:  2016-07-18

7.  Early Restoration of Shank3 Expression in Shank3 Knock-Out Mice Prevents Core ASD-Like Behavioral Phenotypes.

Authors:  Thomas C Jaramillo; Zhong Xuan; Jeremy M Reimers; Christine O Escamilla; Shunan Liu; Craig M Powell
Journal:  eNeuro       Date:  2020-06-12

8.  Early Somatostatin Interneuron Connectivity Mediates the Maturation of Deep Layer Cortical Circuits.

Authors:  Sebnem N Tuncdemir; Brie Wamsley; Floor J Stam; Fumitaka Osakada; Martyn Goulding; Edward M Callaway; Bernardo Rudy; Gord Fishell
Journal:  Neuron       Date:  2016-02-03       Impact factor: 18.688

9.  The Laboratory Rat: Relating Its Age With Human's.

Authors:  Pallav Sengupta
Journal:  Int J Prev Med       Date:  2013-06

10.  Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics.

Authors:  Hilgo Bruining; Richard Hardstone; Erika L Juarez-Martinez; Jan Sprengers; Arthur-Ervin Avramiea; Sonja Simpraga; Simon J Houtman; Simon-Shlomo Poil; Eva Dallares; Satu Palva; Bob Oranje; J Matias Palva; Huibert D Mansvelder; Klaus Linkenkaer-Hansen
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

View more
  3 in total

Review 1.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

2.  Altered Blood Brain Barrier Permeability and Oxidative Stress in Cntnap2 Knockout Rat Model.

Authors:  Idil Memis; Rahul Mittal; Emily Furar; Isaiah White; Rebecca S Eshraghi; Jeenu Mittal; Adrien A Eshraghi
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

Review 3.  Shankopathies in the Developing Brain in Autism Spectrum Disorders.

Authors:  Yukti Vyas; Juliette E Cheyne; Kevin Lee; Yewon Jung; Pang Ying Cheung; Johanna M Montgomery
Journal:  Front Neurosci       Date:  2021-12-22       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.